Sudden onset of colitis after ablation of secretin-expressing lymphocytes in transgenic mice

Experimental Biology and Medicine

Volumn 229, Issue 8, 2004, Pages 826-834

  Rindi, Guido ^a   Civallero, Monica ^b,c   Candusso, Maria Elena ^b   Marchetti, Annalisa ^d   Klersy, Catherine ^d   Nano, Rosanna ^b   Leiter, Andrew B ^e  

^a UNIVERSITY OF PARMA   (Italy)

^b UNIVERSITY OF PAVIA   (Italy)

^c UNIVERSITY OF MODENA AND REGGIO EMILIA   (Italy)

^d FONDAZIONE IRCCS POLICLINICO SAN MATTEO   (Italy)

^e Tupper Research Institute   (United States)

Author keywords

Ablation; Colitis; Cytometry; Sec HSVTK; Secretin; Spleen; Thymus

Indexed keywords

CD103 ANTIGEN; CD19 ANTIGEN; CD3 ANTIGEN; CD4 ANTIGEN; CD8 ANTIGEN; GANCICLOVIR; HORMONE RECEPTOR; MESSENGER RNA; SECRETIN; SECRETIN RECEPTOR; THYMIDINE KINASE; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; B LYMPHOCYTE; BLOOD; CELL COUNT; CELL ISOLATION; CELL STRUCTURE; COLITIS; COLON; CONTROLLED STUDY; FLOW CYTOMETRY; GENE EXPRESSION; GRAFT VERSUS HOST REACTION; HERPES VIRUS; HISTOLOGY; HORMONE SYNTHESIS; IMMUNE SYSTEM; IMMUNOBLOTTING; IMMUNOREACTIVITY; LYMPHOCYTE; LYMPHOID CELL; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; PROMOTER REGION; PROTEIN ISOLATION; QUANTITATIVE ANALYSIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SPLEEN; T LYMPHOCYTE SUBPOPULATION; THYMUS; TRANSGENIC MOUSE; WESTERN BLOTTING;

ANIMALIA; HERPESVIRIDAE; MUS MUSCULUS;

EID: 4444253146     PISSN: 15353702     EISSN: None     Source Type: Journal    
DOI: 10.1177/153537020422900816     Document Type: Article

References (44)

1. Rhefeld JF. The new biology of gastrointestinal hormones. Physiol Rev 78:1087-1108, 1998.
2. Chey WY, Escoffery R. Secretin cells in the gastrointestinal tract. Endocrinology 98:1390-1395, 1976.
3. Larsson LI, Sundler F, Alumets J, Håkanson R, Schaffalinsky De Muckadell DB, Fahrenkrug J. Distribution, ontogeny and ultrastucture of the mammalian secretin cell. Cell Tissue Res 181:361-368, 1977.
4. Wheeler MB, Nishitani J, Buchan AML, Kopin AS, Chey WY, Chang T, Leiter AB. Identification of a transcriptional enhancer important for enteroendocrine and pancreatic islet cell-specific expression of the secretin gene. Mol Cell Biol 12:3531-3539, 1992.
5. Lopez MJ, Upchurch BH, Rindi G, Leiter AB. Studies in transgenic mice reveal potential relationships between secretin-producing cells and other endocrine cell types. J Biol Chem 270:885-981, 1995.
6. Rindi G, Ratineau C, Ronco A, Candusso ME, Tsai M, Leiter AB. Targeted ablation of secretin cells reveals a close developmental relationship with CCK and L cells. Development 126:4149-4156, 1999.
7. Borrelli E, Heyman RA, Lesley J, Arias C, Sawchenko PE, Evans RM. Transgenic mice with inducible dwarfism. Nature 339:538-541, 1989.
8. Johnson FE, LaRegina MC, Devine JE, Hudd C. Effect of chronically administered secretin on the nude mouse. J Surg Oncol 39:84-89, 1988.
9. Gasslander T, Smeds S, Blomqvist L, Ishe I. Proliferative response of different exocrine pancreatic cell types to hormonal stimuli. Scand J Gastroenterol 25:1111-1117, 1990.
10. Langhans N, Rindi G, Chiu M, Rehfeld JF, Ardman B, Beinbom M, Kopin AS. Abnormal gastric histology and decreased acid production in cholecystokinin-B/ gastrin receptor-deficient mice. Gastroenterology 112:280-286, 1997.
11. Davies MD, Parrott DM. Cytotoxic T cells in small intestine epithelial, lamina propria and lung lymphocytes. Immunology 44:367-371, 1981.
12. Rindi G, Grant SGN, Yiangou Y, Gathei M, Bloom SR, Bautch V, Solcia E, Polak JM. Development of neuroendocrine tumours in the gastro-intestinal tract of transgenic mice: heterogeneity of hormone expression. Am J Pathol 136:1349-1363, 1990.
13. Schägger H, von Jagow G. Tricine-sodium dodecyl sulfate- polyacrylamide gel electrophoresis for the separation of proteins in the range from 1 to 100 kDa. Analyt Biochem 166:368-379, 1987.
14. Lane D. Antibodies: A laboratory manual. Cold Spring Harbor Laboratory: Cold Spring Harbor Laboratory Press, 1988.
15. Kopin AS, Wheeler MB, Leiter AB. Secretin: structure of the precursor and tissue distribution of the mRNA. Proc Natl Acad Sci U S A 87:2299-2303, 1990.
16. Gafvelin G, Jörnvall H, Mutt V. Processing of prosecretin: isolation of a secretin precursor from porcine intestine. Proc Natl Acad Sci U S A 87:6781-6785, 1990.
17. Ratineau C, Ronco A, Leiter AB. Role of the amino-terminal domain of Simian Virus 40 early region in inducing tumors in secretin-expressing cells in transgenic mice. Gastroenterology 119:1305-1311, 2000.
18. Fuller PJ, Verity K. Somatostatin gene expression in the thymus gland. J Immunol 143:1015-1017, 1989.
19. Vanneste Y, Thome AN, Vandersmissen E, Charlet C, Franchimont D, Martens H, Lhiaubet AM, Schimpff RM, Rostene W, Geenen V. Identification of neurotensin-related peptides in human thymic epithelial cell membranes and relationship with human histocompatibility complex class I molecules. J Neuroimmunol 76:161-166, 1997.
20. Pugliese A, Zeller M, Fernandez A Jr, Zalcberg LJ, Bertlett RJ, Ricordi C, Pietropaolo M, Eisenbarth GS, Bennet ST, Patel DD. The insulin gene is transcribed in the human thymus and transcription levels correlates with allelic variations at the INS VNTR-IDDM2 susceptibility locus for type I diabetes. Nat Genet 15:293-297, 1997.
21. Reubi JC, Horisberger U, Kappeler A, Laissue JA. Localization of receptors for vasoactive intestinal peptide, somatostatin, and substance P in distinct compartments of human lymphoid tissues. Blood 92:191-197, 1998.
22. Throsby M, Homo-Delarche F, Chevenne D, Goya R, Dardenne M, Pleau JM. Pancreatic hormone expression in the murine thymus: localization in dendritic cells and macrophages. Endocrinology 139:2399-2406, 1998.
23. Hattori N, Saito T, Yagyu T, Jiang BH, Kitagawa K, Inagaki C. GH, GH receptor, GH secretagogue receptor, and ghrelin expression in human T cells, B cells, and neutrophils. J Clin Endocrinol Metab 86:4284-4291, 2001.
24. Geenen V, Martens H, Vandersmissen E, Achour I, Kecha O, Franchimont D. Cellular and molecular aspects of thymic T-cell education in neuroendocrine self principles. Implications for autoimmunity. Ann N Y Acad Sci 8:328-337, 1998.
25. Savino W, Dardenne M. Neuroendocrine control of thymus physiology. Endocrine Rev 21:412-443, 2000.
26. Canfield V, West AB, Goldenring JR, Levenson R. Genetic ablation of parietal cells in transgenic mice: a new model for analyzing cell lineage relationships in the gastric mucosa. Proc Natl Acad Sci U S A 93:2431-2435, 1996.
27. Bush TG, Savidge TG, Freeman TC, Campbell EA, Mucke L, Johnson MH, Sofronjev MV. Fulminant jejuno-ileitis following ablation of enteric glia in adult transgenic mice. Cell 93:189-201, 1998.
28. Sale GE, MacDonald GB, Shulman HM, Thomas ED. Gastrointestinal graft-versus-host disease in man: a clinicopathological study of the rectal biopsy. Am J Surg Pathol 3:291-299, 1979.
29. Rotterdam H, Tsang P. Gastrointestinal disease in the immunocompromised patient. Hum Pathol 25:1123-1140, 1994.
30. Thiele DL, Eigenbrodt ML, Bryde SE, Eigenbrodt EH, Lipsky PE. Intestinal graft-versus-host disease is initiated by donor T cells distinct from classic cytotoxic T lymphocytes. J Clin Invest 84:1947-1956, 1989.
31. Eigenbrodt ML, Eigenbrodt EH, Thiele DL. Histologic similarity of murine colonic graft-versus-host disease (GVHD) to human colonic GVHD and inflammatory bowel disease. Am J Pathol 137:1065-76, 1990.
32. Lampert IA, Thorpe P, Van Noorden S, Marsh J, Goldman JM, Gordon-Smith EC, Evans DJ. Selective sparing of enterochromaffin cells in graft versus host disease affecting the colonic mucosa. Histopathology 9:875-866, 1985.
33. Ryan FP, Smart RC, Holdsworth CD, Preston FE. Hyposplenism in inflammatory bowel disease. Gut 19:50-55, 1978.
34. Ryan FP, Ward AM, Holdsworth CD. Autoimmunity, inflammatory bowel disease and hyposplenism. Q J Med 78:59-63, 1991.
35. Hollander GA, Simpson SJ, Mizoguchi E, Nigiannopoulou A, She J, Gutierrez-Ramos JC, Bahn AK, Burakoff SJ, Wang B, Terhorst C. Severe colitis in mice with aberrant thymic selection. Immunity 3:27-38, 1995.
36. Muller AF, Toghill PJ. Hyposplenism in gastrointestinal disease. Gut 36:165-167, 1995.
37. Ehrhardt RO, Lubviksson B. Induction of colitis in IL-2-deficient mice: the role of thymic and peripheral dysregulation in the generation of autoreactive T cells. Res Immunol 148:582-588, 1997.
38. Okubo K, Kondo N, Okamoto T, Isobe J, Ueno Y. Excision of invasive thymoma: a cure for ulcerative colitis? Amnn Thorac Surg 71:2013-2015, 2001.
39. Groux H, O'Garra A, Bigler M, Rouleau M, Antonenko S, de Vries JE, Roncarolo MG. A CD4+ T-cell subset inhibits antigen-specific T-cell responses and prevents colitis. Nature 389:737-742, 1998.
40. De Winter H, Cheroutre H, Kronenberg M. Mucosal immunity and inflammation. II. The yin and yang of T cells in intestinal inflammation: pathogenic and protective roles in a mouse colitis model. Am J Physiol 276:G1317-G1321, 1999.
41. Kuhn R, Lohler J, Rennick D, Rajewsky K, Muller W. Interleukin-10- deficient mice develop chronic enterocolitis. Cell 75:263-274, 1993.
42. Kullberg MC, Ward JM, Gorelick PL, Caspar P, Hieny S, Cheever A, Jankovic D, Sher A. Helicobacter hepaticus triggers colitis in specific-pathogen-free interleukin-10 (IL-10)-deficient mice through an IL-12- and gamma interferon-dependent mechanism. Infect Immunol 66:5157-5166, 1998.
43. Kullberg MC, Jankovic D, Gorelick PL, Caspar P, Letterio JJ, Cheever AW, Sher A. Bacteria-triggered CD4(+) T regulatory cells suppress Helicobacter hepaticus-induced colitis. J Exp Med 196:505-515, 2002.
44. Kullberg MC, Andersen JF, Gorelick PL, Caspar P, Suerbaum S, Fox JG, Cheever AW, Jankovic D, Sher A. Induction of colitis by a CD4+ T cell clone specific for a bacterial epitope. Proc Natl Acad Sci U S A 100:15830-15835, 2003.